Effects of selective alpha 2-adrenoreceptor stimulation on capsaicin-evoked substance P release from primary cultured dorsal root ganglion neurons. 2010

Huicui Gong, and Qian Liu, and Xiangdong Yang, and Zhen Liu, and Guixiang Liu, and Zhenzhong Li
Department of Anatomy, Shandong University School of Medicine, Jinan, China.

Alpha2 adrenoreceptors are expressed in dorsal root ganglion (DRG) neurons and may be involved in inflammation or other physiological and pathophysiological conditions. To determine the effects of administration of selective alpha2 adrenoreceptor agonists or antagonists on substance P (SP) release from DRG neurons without or with capsaicin stimulation, primary cultured embryonic rat DRG neurons were preincubated with the selective alpha2 adrenoreceptor agonist clonidine (10(-5) mol/L) or the alpha2 adrenoreceptor antagonist yohimbine (10(-5) mol/L) for 4 days, respectively, followed by the addition of capsaicin (10(-7) nmol/L) for additional 10 min. Cultures were examined by radioimmunoassay (RIA) for detecting SP levels released from DRG neurons before and after capsaicin stimulation. Expression of SP mRNA and vanilloid receptor 1 (VR1) mRNA was determined by RT-PCR. Administration of the selective alpha2 adrenoreceptor agonist clonidine for 4 days could decrease capsaicin-evoked SP release but not basal SP release. Administration of clonidine could decrease VR1 mRNA expression but not SP mRNA. Administration of the selective alpha2 adrenoreceptor antagonist yohimbine did not have these effects. The inhibitory role of the selective alpha2 adrenoreceptor agonist clonidine on capsaicin-evoked SP release may be through decreasing VR1 mRNA levels then reducing the sensitivity of nociceptors to capsaicin. The data provided in the present study suggest that adrenergic modulation on primary sensory neurons by an alpha2 adrenoreceptor agonist may contribute to the analgesic effects in neurogenic inflammation.

UI MeSH Term Description Entries
D009474 Neurons The basic cellular units of nervous tissue. Each neuron consists of a body, an axon, and dendrites. Their purpose is to receive, conduct, and transmit impulses in the NERVOUS SYSTEM. Nerve Cells,Cell, Nerve,Cells, Nerve,Nerve Cell,Neuron
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D002211 Capsaicin An alkylamide found in CAPSICUM that acts at TRPV CATION CHANNELS. 8-Methyl-N-Vanillyl-6-Nonenamide,Antiphlogistine Rub A-535 Capsaicin,Axsain,Capsaicine,Capsicum Farmaya,Capsidol,Capsin,Capzasin,Gelcen,Katrum,NGX-4010,Zacin,Zostrix,8 Methyl N Vanillyl 6 Nonenamide,NGX 4010,NGX4010
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D003000 Clonidine An imidazoline sympatholytic agent that stimulates ALPHA-2 ADRENERGIC RECEPTORS and central IMIDAZOLINE RECEPTORS. It is commonly used in the management of HYPERTENSION. Catapres,Catapresan,Catapressan,Chlophazolin,Clofelin,Clofenil,Clonidine Dihydrochloride,Clonidine Hydrochloride,Clonidine Monohydrobromide,Clonidine Monohydrochloride,Clopheline,Dixarit,Gemiton,Hemiton,Isoglaucon,Klofelin,Klofenil,M-5041T,ST-155,Dihydrochloride, Clonidine,Hydrochloride, Clonidine,M 5041T,M5041T,Monohydrobromide, Clonidine,Monohydrochloride, Clonidine,ST 155,ST155
D005727 Ganglia, Spinal Sensory ganglia located on the dorsal spinal roots within the vertebral column. The spinal ganglion cells are pseudounipolar. The single primary branch bifurcates sending a peripheral process to carry sensory information from the periphery and a central branch which relays that information to the spinal cord or brain. Dorsal Root Ganglia,Spinal Ganglia,Dorsal Root Ganglion,Ganglion, Spinal,Ganglia, Dorsal Root,Ganglion, Dorsal Root,Spinal Ganglion
D000316 Adrenergic alpha-Agonists Drugs that selectively bind to and activate alpha adrenergic receptors. Adrenergic alpha-Receptor Agonists,alpha-Adrenergic Receptor Agonists,Adrenergic alpha-Agonist,Adrenergic alpha-Receptor Agonist,Receptor Agonists, Adrenergic alpha,Receptor Agonists, alpha-Adrenergic,alpha-Adrenergic Agonist,alpha-Adrenergic Agonists,alpha-Adrenergic Receptor Agonist,Adrenergic alpha Agonist,Adrenergic alpha Agonists,Adrenergic alpha Receptor Agonist,Adrenergic alpha Receptor Agonists,Agonist, Adrenergic alpha-Receptor,Agonist, alpha-Adrenergic,Agonist, alpha-Adrenergic Receptor,Agonists, Adrenergic alpha-Receptor,Agonists, alpha-Adrenergic,Agonists, alpha-Adrenergic Receptor,Receptor Agonist, alpha-Adrenergic,Receptor Agonists, alpha Adrenergic,alpha Adrenergic Agonist,alpha Adrenergic Agonists,alpha Adrenergic Receptor Agonist,alpha Adrenergic Receptor Agonists,alpha-Agonist, Adrenergic,alpha-Agonists, Adrenergic,alpha-Receptor Agonist, Adrenergic,alpha-Receptor Agonists, Adrenergic
D000317 Adrenergic alpha-Antagonists Drugs that bind to but do not activate alpha-adrenergic receptors thereby blocking the actions of endogenous or exogenous adrenergic agonists. Adrenergic alpha-antagonists are used in the treatment of hypertension, vasospasm, peripheral vascular disease, shock, and pheochromocytoma. Adrenergic alpha-Receptor Blockaders,alpha-Adrenergic Blocking Agents,alpha-Adrenergic Receptor Blockaders,alpha-Blockers, Adrenergic,Adrenergic alpha-Blockers,alpha-Adrenergic Antagonists,alpha-Adrenergic Blockers,Adrenergic alpha Antagonists,Adrenergic alpha Blockers,Adrenergic alpha Receptor Blockaders,Agents, alpha-Adrenergic Blocking,Antagonists, alpha-Adrenergic,Blockaders, Adrenergic alpha-Receptor,Blockaders, alpha-Adrenergic Receptor,Blockers, alpha-Adrenergic,Blocking Agents, alpha-Adrenergic,Receptor Blockaders, alpha-Adrenergic,alpha Adrenergic Antagonists,alpha Adrenergic Blockers,alpha Adrenergic Blocking Agents,alpha Adrenergic Receptor Blockaders,alpha Blockers, Adrenergic,alpha-Antagonists, Adrenergic,alpha-Receptor Blockaders, Adrenergic
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated

Related Publications

Huicui Gong, and Qian Liu, and Xiangdong Yang, and Zhen Liu, and Guixiang Liu, and Zhenzhong Li
December 2008, Neuro endocrinology letters,
Huicui Gong, and Qian Liu, and Xiangdong Yang, and Zhen Liu, and Guixiang Liu, and Zhenzhong Li
December 2006, European journal of pharmacology,
Huicui Gong, and Qian Liu, and Xiangdong Yang, and Zhen Liu, and Guixiang Liu, and Zhenzhong Li
September 2016, American journal of physical medicine & rehabilitation,
Huicui Gong, and Qian Liu, and Xiangdong Yang, and Zhen Liu, and Guixiang Liu, and Zhenzhong Li
June 2006, Journal of neurochemistry,
Huicui Gong, and Qian Liu, and Xiangdong Yang, and Zhen Liu, and Guixiang Liu, and Zhenzhong Li
December 2006, Neuro endocrinology letters,
Huicui Gong, and Qian Liu, and Xiangdong Yang, and Zhen Liu, and Guixiang Liu, and Zhenzhong Li
June 2000, Biochemical pharmacology,
Huicui Gong, and Qian Liu, and Xiangdong Yang, and Zhen Liu, and Guixiang Liu, and Zhenzhong Li
November 1997, The American journal of physiology,
Huicui Gong, and Qian Liu, and Xiangdong Yang, and Zhen Liu, and Guixiang Liu, and Zhenzhong Li
April 2012, Molecular medicine reports,
Huicui Gong, and Qian Liu, and Xiangdong Yang, and Zhen Liu, and Guixiang Liu, and Zhenzhong Li
August 1997, Biochemical Society transactions,
Huicui Gong, and Qian Liu, and Xiangdong Yang, and Zhen Liu, and Guixiang Liu, and Zhenzhong Li
July 1979, Brain research,
Copied contents to your clipboard!